Based on the analysis of Ocean Biomedical's profitability, liquidity, and operating efficiency, Ocean Biomedical may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, Ocean Biomedical's Total Assets are fairly stable compared to the past year. Total Stockholder Equity is likely to climb to about 125.9 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 3.5 M in 2024. Key indicators impacting Ocean Biomedical's financial strength include:
The essential information of the day-to-day investment outlook for Ocean Biomedical includes many different criteria found on its balance sheet. An individual investor should monitor Ocean Biomedical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Ocean Biomedical.
Net Income
534,369
Ocean
Select Account or Indicator
Ptb Ratio
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Pb Ratio
Free Cash Flow Per Share
Roic
Net Income Per Share
Pocfratio
Pfcf Ratio
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Current Ratio
Tangible Book Value Per Share
Graham Number
Shareholders Equity Per Share
Graham Net Net
Enterprise Value Over E B I T D A
Price Earnings Ratio
Price Book Value Ratio
Price Earnings To Growth Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Effective Tax Rate
Company Equity Multiplier
Return On Capital Employed
Quick Ratio
Price To Book Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Return On Assets
Price Fair Value
Return On Equity
Change In Cash
Free Cash Flow
Change In Working Capital
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Other Cashflows From Financing Activities
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Retained Earnings
Accounts Payable
Non Current Assets Total
Common Stock Shares Outstanding
Total Liab
Net Invested Capital
Total Current Assets
Capital Stock
Net Working Capital
Cash
Liabilities And Stockholders Equity
Other Current Assets
Depreciation And Amortization
Selling General Administrative
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Research Development
Ebitda
Total Operating Expenses
Income Before Tax
Income Tax Expense
Total Other Income Expense Net
Probability Of Bankruptcy
Understanding current and past Ocean Biomedical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ocean Biomedical's financial statements are interrelated, with each one affecting the others. For example, an increase in Ocean Biomedical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Ocean Biomedical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ocean Biomedical. Check Ocean Biomedical's Beneish M Score to see the likelihood of Ocean Biomedical's management manipulating its earnings.
Comparative valuation techniques use various fundamental indicators to help in determining Ocean Biomedical's current stock value. Our valuation model uses many indicators to compare Ocean Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ocean Biomedical competition to find correlations between indicators driving Ocean Biomedical's intrinsic value. More Info.
Ocean Biomedical is rated below average in number of shares shorted category among its peers. It is considered to be number one stock in ebitda category among its peers . At this time, Ocean Biomedical's EBITDA is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ocean Biomedical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Ocean Biomedical Systematic Risk
Ocean Biomedical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ocean Biomedical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Ocean Biomedical correlated with the market. If Beta is less than 0 Ocean Biomedical generally moves in the opposite direction as compared to the market. If Ocean Biomedical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ocean Biomedical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ocean Biomedical is generally in the same direction as the market. If Beta > 1 Ocean Biomedical moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Ocean Biomedical is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Ocean has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Ocean Biomedical's financials are consistent with your investment objective using the following steps:
Review Ocean Biomedical's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
Study the cash flow inflows and outflows to understand Ocean Biomedical's liquidity and solvency.
Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
Compare Ocean Biomedical's financials to those of its peers to see how it stacks up and identify any potential red flags.
Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Ocean Biomedical's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.
Today, most investors in Ocean Biomedical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ocean Biomedical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ocean Biomedical growth as a starting point in their analysis.
Ocean Biomedical November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ocean Biomedical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ocean Biomedical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ocean Biomedical based on widely used predictive technical indicators. In general, we focus on analyzing Ocean Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ocean Biomedical's daily price indicators and compare them against related drivers.
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.